These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22519450)

  • 21. Matrix metalloproteinases: a review of their structure and role in systemic sclerosis.
    Peng WJ; Yan JW; Wan YN; Wang BX; Tao JH; Yang GJ; Pan HF; Wang J
    J Clin Immunol; 2012 Dec; 32(6):1409-14. PubMed ID: 22767184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases and atherogenesis in dependence of age.
    Kunz J
    Gerontology; 2007; 53(2):63-73. PubMed ID: 17047333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
    Hlatky MA; Ashley E; Quertermous T; Boothroyd DB; Ridker P; Southwick A; Myers RM; Iribarren C; Fortmann SP; Go AS;
    Am Heart J; 2007 Dec; 154(6):1043-51. PubMed ID: 18035073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischaemia and reperfusion.
    Wainwright CL
    Curr Opin Pharmacol; 2004 Apr; 4(2):132-8. PubMed ID: 15063356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation of matrix metalloproteinase enzyme in HIV-associated neurocognitive disorder.
    Singh H; Nain S; Krishnaraj A; Lata S; Dhole TN
    Gene; 2019 May; 698():41-49. PubMed ID: 30825593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
    Liu N; Zhou B; Zhu G
    Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial extracellular matrix remodeling in ischemic heart failure.
    Gallagher GL; Jackson CJ; Hunyor SN
    Front Biosci; 2007 Jan; 12():1410-9. PubMed ID: 17127391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.
    Brown BA; Williams H; George SJ
    Prog Mol Biol Transl Sci; 2017; 147():197-237. PubMed ID: 28413029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.
    Terashima M; Akita H; Kanazawa K; Inoue N; Yamada S; Ito K; Matsuda Y; Takai E; Iwai C; Kurogane H; Yoshida Y; Yokoyama M
    Circulation; 1999 Jun; 99(21):2717-9. PubMed ID: 10351963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.
    DeLeon-Pennell KY; Meschiari CA; Jung M; Lindsey ML
    Prog Mol Biol Transl Sci; 2017; 147():75-100. PubMed ID: 28413032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y
    J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases in cardiovascular disease.
    Liu P; Sun M; Sader S
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):25B-30B. PubMed ID: 16498509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of inflammation and metalloproteinases in plaque disruption and thrombosis.
    Shah PK
    Vasc Med; 1998; 3(3):199-206. PubMed ID: 9892512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.